Many neurological, autoimmune, and intracellular systemic challenges are complicated by the presence of biofilm infections. In these conditions, treatment is often more challenging as biofilm-generating pathogens can hide within the central nervous system, fatty tissues, or within the cells themselves. Biocidin®LSF uses liposomal technology to deliver Biocidin® straight into the bloodstream and the lymph for rapid systemic support. Lyme-literate practitioners appreciate liposomal delivery of Biocidin® for its enhanced intracellular uptake as demonstrated in our research.